RATIONALE AND OBJECTIVES: Pulmonary functional imaging using four-dimensional x-ray computed tomographic (4DCT) imaging and hyperpolarized (3)He magnetic resonance imaging (MRI) provides regional lung function estimates in patients with lung cancer in whom pulmonary function measurements are typically dominated by tumor burden. The aim of this study was to evaluate the quantitative spatial relationship between 4DCT and hyperpolarized (3)He MRI ventilation maps. MATERIALS AND METHODS: Eleven patients with lung cancer provided written informed consent to 4DCT imaging and MRI performed within 11 ± 14 days. Hyperpolarized (3)He MRI was acquired in breath-hold after inhalation from functional residual capacity of 1 L hyperpolarized (3)He, whereas 4DCT imaging was acquired over a single tidal breath of room air. For hyperpolarized (3)He MRI, the percentage ventilated volume was generated using semiautomated segmentation; for 4DCT imaging, pulmonary function maps were generated using the correspondence between identical tissue elements at inspiratory and expiratory phases to generate percentage ventilated volume. RESULTS: After accounting for differences in image acquisition lung volumes ((3)He MRI: 1.9 ± 0.5 L ipsilateral, 2.3 ± 0.7 L contralateral; 4DCT imaging: 1.2 ± 0.3 L ipsilateral, 1.3 ± 0.4 L contralateral), there was no significant difference in percentage ventilated volume between hyperpolarized (3)He MRI (72 ± 11% ipsilateral, 79 ± 12% contralateral) and 4DCT imaging (74 ± 3% ipsilateral, 75 ± 4% contralateral). Spatial correspondence between 4DCT and (3)He MRI ventilation was evaluated using the Dice similarity coefficient index (ipsilateral, 86 ± 12%; contralateral, 88 ± 12%). CONCLUSIONS: Despite rather large differences in image acquisition breathing maneuvers, good spatial and significant quantitative agreement was observed for ventilation maps on hyperpolarized (3)He MRI and 4DCT imaging, suggesting that pulmonary regions with good lung function are similar between modalities in this small group of patients with lung cancer.
RATIONALE AND OBJECTIVES: Pulmonary functional imaging using four-dimensional x-ray computed tomographic (4DCT) imaging and hyperpolarized (3)He magnetic resonance imaging (MRI) provides regional lung function estimates in patients with lung cancer in whom pulmonary function measurements are typically dominated by tumor burden. The aim of this study was to evaluate the quantitative spatial relationship between 4DCT and hyperpolarized (3)He MRI ventilation maps. MATERIALS AND METHODS: Eleven patients with lung cancer provided written informed consent to 4DCT imaging and MRI performed within 11 ± 14 days. Hyperpolarized (3)He MRI was acquired in breath-hold after inhalation from functional residual capacity of 1 L hyperpolarized (3)He, whereas 4DCT imaging was acquired over a single tidal breath of room air. For hyperpolarized (3)He MRI, the percentage ventilated volume was generated using semiautomated segmentation; for 4DCT imaging, pulmonary function maps were generated using the correspondence between identical tissue elements at inspiratory and expiratory phases to generate percentage ventilated volume. RESULTS: After accounting for differences in image acquisition lung volumes ((3)He MRI: 1.9 ± 0.5 L ipsilateral, 2.3 ± 0.7 L contralateral; 4DCT imaging: 1.2 ± 0.3 L ipsilateral, 1.3 ± 0.4 L contralateral), there was no significant difference in percentage ventilated volume between hyperpolarized (3)He MRI (72 ± 11% ipsilateral, 79 ± 12% contralateral) and 4DCT imaging (74 ± 3% ipsilateral, 75 ± 4% contralateral). Spatial correspondence between 4DCT and (3)He MRI ventilation was evaluated using the Dice similarity coefficient index (ipsilateral, 86 ± 12%; contralateral, 88 ± 12%). CONCLUSIONS: Despite rather large differences in image acquisition breathing maneuvers, good spatial and significant quantitative agreement was observed for ventilation maps on hyperpolarized (3)He MRI and 4DCT imaging, suggesting that pulmonary regions with good lung function are similar between modalities in this small group of patients with lung cancer.
Authors: Sanghun Choi; Eric A Hoffman; Sally E Wenzel; Merryn H Tawhai; Youbing Yin; Mario Castro; Ching-Long Lin Journal: J Appl Physiol (1985) Date: 2013-06-06
Authors: Tokihiro Yamamoto; Sven Kabus; Cristian Lorenz; Eric Johnston; Peter G Maxim; Maximilian Diehn; Neville Eclov; Cristian Barquero; Billy W Loo; Paul J Keall Journal: Med Phys Date: 2013-10 Impact factor: 4.071
Authors: John Kipritidis; Bilal A Tahir; Guillaume Cazoulat; Michael S Hofman; Shankar Siva; Jason Callahan; Nicholas Hardcastle; Tokihiro Yamamoto; Gary E Christensen; Joseph M Reinhardt; Noriyuki Kadoya; Taylor J Patton; Sarah E Gerard; Isabella Duarte; Ben Archibald-Heeren; Mikel Byrne; Rick Sims; Scott Ramsay; Jeremy T Booth; Enid Eslick; Fiona Hegi-Johnson; Henry C Woodruff; Rob H Ireland; Jim M Wild; Jing Cai; John E Bayouth; Kristy Brock; Paul J Keall Journal: Med Phys Date: 2019-02-01 Impact factor: 4.071
Authors: Douglas Brennan; Leah Schubert; Quentin Diot; Richard Castillo; Edward Castillo; Thomas Guerrero; Mary K Martel; Derek Linderman; Laurie E Gaspar; Moyed Miften; Brian D Kavanagh; Yevgeniy Vinogradskiy Journal: Int J Radiat Oncol Biol Phys Date: 2015-03-25 Impact factor: 7.038
Authors: Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills Journal: Int J Radiat Oncol Biol Phys Date: 2018-10-18 Impact factor: 7.038
Authors: Yevgeniy Vinogradskiy; Phillip J Koo; Richard Castillo; Edward Castillo; Thomas Guerrero; Laurie E Gaspar; Moyed Miften; Brian D Kavanagh Journal: Int J Radiat Oncol Biol Phys Date: 2014-05-01 Impact factor: 7.038